Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3181484 | Actas Dermo-Sifiliográficas | 2008 | 6 Pages |
Abstract
Our clinical experience with the use of etanercept for treating plaque psoriasis shows a favorable efficacy and safety profile. We propose a standardized procedure for consultations with psoriasis patients involving extensive data collection on each visit and the creation of a national surveillance system for patients under treatment with biologic agents.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
B. MartÃn, J.L. Sánchez-Carazo, A. Pérez-Ferriols, C. Laguna, V. Oliver, V. Alegre,